SINGAPORE (June 30): CGS-CIMB analyst Ngoh Yi Sin is maintaining “buy” on IHH Healthcare with a target price of RM6.25 ($2.03), which is based on an unchanged sum-of-the-parts (SOTP) valuation.

The rating comes after the release of IHH Healthcare’s 1Q20 results on Monday. The private healthcare operator posted a loss of RM319.8 million.

See: IHH Healthcare reports loss of RM319.8 mil for 1Q20

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook